EMEA-002352-PIP01-18

Key facts

Active substance
Irbesartan / amlodipine
Therapeutic area
Cardiovascular diseases
Decision number
P/0245/2018
PIP number
EMEA-002352-PIP01-18
Pharmaceutical form(s)
Film-coated tablet
Condition(s) / indication(s)
Treatment of hypertension
Route(s) of administration
Oral use
Contact for public enquiries
Sanofi- Aventis Research & Development

Tel.  +33 169745695
E-mail: contact-us@sanofi.com

Decision type
W: decision granting a waiver in all age groups for all conditions/indications

Decision

How useful was this page?

Add your rating